The DNA methylation landscape in cancer

  • Ksenia Skvortsova
    Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney 2010, New South Wales, Australia
  • Clare Stirzaker
    Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney 2010, New South Wales, Australia
  • Phillippa Taberlay
    School of Medicine, College of Health and Medicine, University of Tasmania, Hobart 7001, Tasmania, Australia

Description

<jats:title>Abstract</jats:title> <jats:p>As one of the most abundant and well-studied epigenetic modifications, DNA methylation plays an essential role in normal development and cellular biology. Global alterations to the DNA methylation landscape contribute to alterations in the transcriptome and deregulation of cellular pathways. Indeed, improved methods to study DNA methylation patterning and dynamics at base pair resolution and across individual DNA molecules on a genome-wide scale has highlighted the scope of change to the DNA methylation landscape in disease states, particularly during tumorigenesis. More recently has been the development of DNA hydroxymethylation profiling techniques, which allows differentiation between 5mC and 5hmC profiles and provides further insights into DNA methylation dynamics and remodeling in tumorigenesis. In this review, we describe the distribution of DNA methylation and DNA hydroxymethylation in different genomic contexts, first in normal cells, and how this is altered in cancer. Finally, we discuss DNA methylation profiling technologies and the most recent advances in single-cell methods, bisulfite-free approaches and ultra-long read sequencing techniques.</jats:p>

Journal

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top